Your browser doesn't support javascript.
loading
Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma.
Bagherlou, Nazanin; Farajnia, Safar; Zahri, Saber; Dastranj Tabrizi, Ali; Nazari, Atefeh.
Afiliación
  • Bagherlou N; Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, Iran.
  • Farajnia S; Women's Reproduction Health Research Center, Tabriz University of Medical Science, Tabriz, Iran.
  • Zahri S; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Dastranj Tabrizi A; Biotechnology Research Center, Tabriz University of Medical Science, Tabriz, Iran.
  • Nazari A; Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, Iran.
Caspian J Intern Med ; 11(1): 75-82, 2020.
Article en En | MEDLINE | ID: mdl-32042390
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Caspian J Intern Med Año: 2020 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Caspian J Intern Med Año: 2020 Tipo del documento: Article País de afiliación: Irán